 It's only the second drug that's been convincingly shown to slow the memory-destroying condition. The Food and Drug Administration approved Eli Lilly's medication Tuesday for patients with early or mild cases of dementia caused by Alzheimer's. On Wall Street, thou art by 162 points. More at townhall.com.